Age-related macular degeneration (AMD) and its neovascular complications cause permanent loss of central vision and legal blindness. There is currently no cure for macular degeneration. Treatment for AMD and its neovascular complications has been hampered by a lack of relevant animal models. Recently, however, at least half a dozen mutations in the Tissue Inhibitor of Metalloproteinases-3-encoding gene (TIMP-3) were identified in patients with Sorsby's fundus dystrophy (SFD) (1-3), a disease with similarities to neovascular AMD (4). Mice transgenic for one of these mutations, Y172C, were generated and found to possess retinal pathology culminating in retinal degeneration and subretinal neovascularization, as found in SFD. These TIMP-3/172 mice will provide insights into the pathogenesis of and a means to test potential treatments for macular degeneration. This proposal aims to delineate pathogenic mechanisms accounting for disease in the TIMP-3/172 mice and their human counterparts. Characterization of the pathogenic basis of this disease could suggest therapeutic approaches for treating SFD and other forms of macular degeneration. The project will have 3 components: The first will be to evaluate the effects of the TIMP-3/172 mutation on TIMP-3 function and on angiogenesis. The second will be to identify genetic variables that modify disease progression in the mutant TIMP-3 transgenic mice. Finally, patterns of gene expression in diseased retinal cells in the TIMP-3 transgenic mice will be evaluated and compared with those in unaffected cells. These studies aim to reveal specific biological pathways relevant to the pathology in this animal model. Any such pathways could potentially be manipulated in the future to slow/prevent the disease process.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY012156-07
Application #
6765937
Study Section
Visual Sciences C Study Section (VISC)
Program Officer
Dudley, Peter A
Project Start
1998-03-01
Project End
2006-06-30
Budget Start
2004-07-01
Budget End
2006-06-30
Support Year
7
Fiscal Year
2004
Total Cost
$387,863
Indirect Cost
Name
University of Pennsylvania
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Lebherz, Corinna; Maguire, Albert M; Auricchio, Alberto et al. (2005) Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor. Diabetes 54:1141-9
Lebherz, Corinna; Auricchio, Alberto; Maguire, Albert M et al. (2005) Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates. Hum Gene Ther 16:178-86
Cideciyan, Artur V; Swider, Malgorzata; Aleman, Tomas S et al. (2005) ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina. Invest Ophthalmol Vis Sci 46:4739-46
Rex, Tonia S; Peet, John A; Surace, Enrico M et al. (2005) The distribution, concentration, and toxicity of enhanced green fluorescent protein in retinal cells after genomic or somatic (virus-mediated) gene transfer. Mol Vis 11:1236-45
Schuettauf, Frank; Vorwerk, Christian; Naskar, Rita et al. (2004) Adeno-associated viruses containing bFGF or BDNF are neuroprotective against excitotoxicity. Curr Eye Res 29:379-86
Dejneka, Nadine S; Surace, Enrico M; Aleman, Tomas S et al. (2004) In utero gene therapy rescues vision in a murine model of congenital blindness. Mol Ther 9:182-8
Wong, Wai T; Rex, Tonia S; Auricchio, Alberto et al. (2004) Effect of over-expression of pigment epithelium derived factor (PEDF) on developing retinal vasculature in the mouse. Mol Vis 10:837-44
Dejneka, Nadine S; Kuroki, Akiko M; Fosnot, Joshua et al. (2004) Systemic rapamycin inhibits retinal and choroidal neovascularization in mice. Mol Vis 10:964-72
Cideciyan, Artur V; Aleman, Tomas S; Swider, Malgorzata et al. (2004) Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet 13:525-34
Rex, Tonia S; Allocca, Mariacarmela; Domenici, Luciano et al. (2004) Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Mol Ther 10:855-61

Showing the most recent 10 out of 33 publications